All In MedTech

PMA device

Paradigm Real-Time Insulin Pump

Medtronic Minimed · Sensor, Glucose, Invasive (MDS, Class III) · First FDA decision Dec 16, 2008, newest Aug 25, 2015Diabetes

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

4

PMA pathway

Device trials

12

Naming "Paradigm Real-Time Insulin"

MAUDE reports

133,322

Brand "Paradigm Real-Time Insulin", since 2015

PubMed studies

0

Mentioning "Paradigm Real-Time Insulin"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing Paradigm Real-Time Insulin Pump

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 4 of 4 decisions filed under this name.

1 more FDA decisions with a free account

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.

Clinical trials

Device studies on ClinicalTrials.gov that name "Paradigm Real-Time Insulin", any status and sponsor, newest update first.

Open in Trial Radar

9 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Paradigm Real-Time Insulin", and for the whole product code for context.

This brand

133,322 reports: 125,010 malfunction, 8,140 injury, 154 death

Whole product code MDS

232,139 reports: 226,671 malfunction, 5,201 injury, 215 death

Newest reports for this brand

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

11 more recall records with a free account

Published research

The most relevant PubMed records for "Paradigm Real-Time Insulin"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

No PubMed record mentions this device by name.

Other devices of this type

Also filed under product code MDS.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.